 |
| Epidron® Pamphlet |
EPIDRON®
(dexamethasone sodium phosphate,) Injection
Full prescribing information is available to the physician
Full prescribing information is available to the physician
Composition:
4 mg I ml Dexamethasone sodium phosphate
Indications:
Systemic administration:
EPIDRON® injection is a potent, highly effective and versatile corticosteroid preparation which, being a true solution, may be administered intravenously as well as intramuscularly in the treatment of acute disorders responsive to corticosteroid therapy.
Local administration:
It may also be used as local therapy by intra-articular, intrabursal and soft-tissue injection.
Dosage And Administration:
The appropriate dosage should be recommended by your physician intravenous and intramuscular injection.
The usual initial dose is 0.5 mg to 20 mg depending on the severity of the condition. The initial dose should be maintained or adjusted until adequate response is reached. Dosage requirements are variable and must be individualized on the basis of the disease under treatment and the response of the patient.
After initial improvement, single doses of 0.5 cc to 1 cc repeated as necessary may be sufficient. The total daily dosage usually need not exceed 20 cc (80 mg) even in severe conditions.
Contraindications:
Systemic fungal infections.
Hypersensitivity to any component of this drug.
EPIDRON® injection is a potent, highly effective and versatile corticosteroid preparation which, being a true solution, may be administered intravenously as well as intramuscularly in the treatment of acute disorders responsive to corticosteroid therapy.
Local administration:
It may also be used as local therapy by intra-articular, intrabursal and soft-tissue injection.
Dosage And Administration:
The appropriate dosage should be recommended by your physician intravenous and intramuscular injection.
The usual initial dose is 0.5 mg to 20 mg depending on the severity of the condition. The initial dose should be maintained or adjusted until adequate response is reached. Dosage requirements are variable and must be individualized on the basis of the disease under treatment and the response of the patient.
After initial improvement, single doses of 0.5 cc to 1 cc repeated as necessary may be sufficient. The total daily dosage usually need not exceed 20 cc (80 mg) even in severe conditions.
Contraindications:
Systemic fungal infections.
Hypersensitivity to any component of this drug.
Precautions:
Corticosteroids may exacerbate systemic infections, including systemic fungal infections and tuberculosis, and should not be used unless they are needed to control drug reactions under medical supervision. Use in pregnancy and the nursing mother: Since adequate human reproduction studies have not been done with corticosteroids, the use of these drugs in pregnancy or in women of childbearing potential requires that the potential benefits of the drug be weighed against possible hazards to the mother, embryo or foetus. Infants born by mothers who have received substantial doses of corticosteroids during pregnancy should be carefully observed for signs of hypoadrenalism. Corticosteroids appear in breast milk and could suppress growth, interfere with endogenous corticosteroid production, or other unwanted reactions, mothers taking pharmacological doses of corticosteroids should not nurse. You should inform your physician if you are taking any other medications. For additional precautions please consult your physician.
Side effects:
Should side effects or any unusual feeling or symptom occur, a physician should be consulted immediately.
Corticosteroids may exacerbate systemic infections, including systemic fungal infections and tuberculosis, and should not be used unless they are needed to control drug reactions under medical supervision. Use in pregnancy and the nursing mother: Since adequate human reproduction studies have not been done with corticosteroids, the use of these drugs in pregnancy or in women of childbearing potential requires that the potential benefits of the drug be weighed against possible hazards to the mother, embryo or foetus. Infants born by mothers who have received substantial doses of corticosteroids during pregnancy should be carefully observed for signs of hypoadrenalism. Corticosteroids appear in breast milk and could suppress growth, interfere with endogenous corticosteroid production, or other unwanted reactions, mothers taking pharmacological doses of corticosteroids should not nurse. You should inform your physician if you are taking any other medications. For additional precautions please consult your physician.
Side effects:
Should side effects or any unusual feeling or symptom occur, a physician should be consulted immediately.
For the Medical Professcr OnI
EEEEEEEEEEEEEEEEEEEE EIPItI EEEEEEEEEEEEEEEEEEEEEEEEEEEEEE
EPIDRON®
EEEEEEEEEEEEEEEEEEEE EIPItI EEEEEEEEEEEEEEEEEEEEEEEEEEEEEE
EPIDRON®
Packing:
EPIDRON® injection is available in 2 ml vials
EPIDRON® injection is available in 2 ml vials
This is a Medicament
•Medicament is a product which affects your health, and its consumption contrary to instructions is dangerous for you.
•Follow strictly the doctor’s prescription, the method of use, and the instructions of the pharmacist who sold the medicament.
•The doctor and the pharmacist are experts in medicine, its benefits and risks.
•Do not by yourself interrupt the period of treatment prescribed.
•Do not repeat the same prescription without consulting your doctor.
•keep medicines out of the reach of children.
05-03-20 O4PMS: BLACK C D.: 16OX16OMM 314 700 PAM 000
MANUFACTURED BY E.I.P.I.CO.
EGYPTIAN INT. PHARMACEUTICAL INDUSTRIES CO.
TENTH OF RAMADAN CITY A.R.E.
•Medicament is a product which affects your health, and its consumption contrary to instructions is dangerous for you.
•Follow strictly the doctor’s prescription, the method of use, and the instructions of the pharmacist who sold the medicament.
•The doctor and the pharmacist are experts in medicine, its benefits and risks.
•Do not by yourself interrupt the period of treatment prescribed.
•Do not repeat the same prescription without consulting your doctor.
•keep medicines out of the reach of children.
05-03-20 O4PMS: BLACK C D.: 16OX16OMM 314 700 PAM 000
MANUFACTURED BY E.I.P.I.CO.
EGYPTIAN INT. PHARMACEUTICAL INDUSTRIES CO.
TENTH OF RAMADAN CITY A.R.E.
No comments:
Post a Comment